Danaher Corporation (DHR): Price and Financial Metrics


Danaher Corporation (DHR)

Today's Latest Price: $236.11 USD

0.64 (-0.27%)

Updated Jan 19 7:00pm

Add DHR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 88 in Industrial - Machinery

See all "A" rated Strong Buy stocks

DHR Stock Summary

  • With a market capitalization of $168,181,865,312, Danaher Corp has a greater market value than 98.9% of US stocks.
  • Danaher Corp's stock had its IPO on November 5, 1987, making it an older stock than 90.68% of US equities in our set.
  • The price/operating cash flow metric for Danaher Corp is higher than 85.59% of stocks in our set with a positive cash flow.
  • If you're looking for stocks that are quantitatively similar to Danaher Corp, a group of peers worth examining would be MDT, NVO, TMUS, SAP, and COST.
  • DHR's SEC filings can be seen here. And to visit Danaher Corp's official web site, go to www.danaher.com.

DHR Stock Price Chart Interactive Chart >

Price chart for DHR

DHR Price/Volume Stats

Current price $236.11 52-week high $248.32
Prev. close $236.75 52-week low $119.60
Day low $235.45 Volume 2,255,800
Day high $239.65 Avg. volume 2,800,136
50-day MA $227.97 Dividend yield 0.3%
200-day MA $199.27 Market Cap 167.73B

Danaher Corporation (DHR) Company Bio


Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company was founded in 1969 and is based in Washington, the District of Columbia.

DHR Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$236.11$63.69 -73%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Danaher Corp. To summarize, we found that Danaher Corp ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for DHR, they are:

  • The company's debt burden, as measured by earnings divided by interest payments, is 19.17 -- which is good for besting 81.02% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • DHR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 31.16% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-74%
1%-73%
2%-73%
3%-73%
4%-73%
5%-72%

WAT, CDNA, CNC, IDXX, and ILMN can be thought of as valuation peers to DHR, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


DHR Latest News Stream


Event/Time News Detail
Loading, please wait...

DHR Latest Social Stream


Loading social stream, please wait...

View Full DHR Social Stream

Latest DHR News From Around the Web

Below are the latest news stories about Danaher Corp that investors may wish to consider to help them evaluate DHR as an investment opportunity.

Centrifuge Market Increasing Demand for Efficient Management Practices Report Till 2027 with Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific

Centrifuges help in the separation of two different substances, which have a difference in their densities. They can also be essentially used to separate densities with almost indistinguishable densities. Additionally, they can be used to separate insoluble particulates in a

OpenPR | January 18, 2021

RBC Capital Stick to Their Hold Rating for Danaher Corp. By Investing.com

RBC Capital Stick to Their Hold Rating for Danaher Corp.

Investing.com | January 18, 2021

Blood Management Devices Market Trends, Business Opportunities and to See Huge Growth by 2026 | Danaher Corporation, Becton, Dickinson and Company, Terumo BCT, Roche and Haemonetics Corporation

ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Blood Management Devices Key Trends and Opportunities to 2026”. The Global Blood Management Devices Market Report is a professional and in-depth study on the current state of

OpenPR | January 16, 2021

Danaher (DHR) Presents at 39th Annual JP Morgan Healthcare Conference - Slideshow

The following slide deck was published by Danaher Corporation in conjunction with this event....

SA Transcripts on Seeking Alpha | January 15, 2021

Clinical Microbiology Market worth $5.3 billion by 2025 - Leading Key Players are bioMérieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US)

According to the new market research report "Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, Std, Uti), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) - Global Forecast to 2025", published by MarketsandMarkets™, the

OpenPR | January 15, 2021

Read More 'DHR' Stories Here

DHR Price Returns

1-mo 4.51%
3-mo 4.30%
6-mo 18.72%
1-year N/A
3-year 138.42%
5-year 187.66%
YTD 6.29%
2020 45.34%
2019 49.55%
2018 11.80%
2017 20.01%
2016 -15.65%

DHR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full DHR Dividend History

Continue Researching DHR

Want to see what other sources are saying about Danaher Corp's financials and stock price? Try the links below:

Danaher Corp (DHR) Stock Price | Nasdaq
Danaher Corp (DHR) Stock Quote, History and News - Yahoo Finance
Danaher Corp (DHR) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9241 seconds.